Readiness to Change and Prospective Effects of Weight Management Programs in Pediatric Nonalcoholic Fatty Liver Disease

被引:2
|
作者
Slowik, Voytek [1 ]
Wasserkrug, Heather [1 ]
Fischer, Ryan T. [1 ]
Connelly, Mark [2 ]
Deacy, Amanda D. [1 ,2 ]
Hampl, Sarah [3 ,4 ]
Daniel, James F. [1 ]
机构
[1] Univ Missouri, Div Pediat Gastroenterol, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[2] Univ Missouri, Div Dev & Behav Hlth, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[3] Univ Missouri, Div Gen Acad Pediat, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
[4] Univ Missouri, Ctr Childrens Hlth Lifestyles & Nutr, Childrens Mercy Kansas City, Kansas City Sch Med, Kansas City, MO USA
来源
关键词
OF-THE-LITERATURE; ADOLESCENT OVERWEIGHT; OBESITY; INTERVENTION; CHILDREN; OUTCOMES; MOTIVATION; ATTENDANCE; RISK;
D O I
10.1111/cts.12913
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Non-alcoholic fatty liver disease (NAFLD) is an increasing problem in pediatrics with limited treatment options. We prospectively assessed outcomes in patients managed in a hepatology clinic (HC) alone vs. those managed in combination with a multidisciplinary weight management program (MWMP). We describe each group's readiness to change at the time of NAFLD diagnosis. Patients diagnosed with NAFLD were given a modified Stages of Change Readiness and Treatment Eagerness Scale (SOCRATES) at enrollment (T1) to assess readiness to change. They were then followed at 3-9 months (T2) and at 10-15 months (T3). Linear mixed models were used to evaluate changes in body mass index (BMI), BMI z-score, and transaminases over time and between the two groups. There were no significant treatment group main effects or treatment x time interactions for our primary end points for HC alone (n = 75) or with MWMP (n = 18). There was a significant main effect for time for BMI z-score, with BMI z-scores declining on average by 0.0568 (P = 0.004) from visit to visit. Low SOCRATES subscales scores in HC alone (n = 33) or with MWMP (n = 4) suggested a patient population with low recognition of disease and likelihood of taking steps for change. Patients with obesity and NAFLD had low scores on all three SOCRATES subscales. Despite this, both groups had improvement in BMI z-score without significant difference between the two treatment groups in other primary end points. Further study is needed to identify the most effective patient selection and treatment strategies for pediatric patients with NAFLD, including pharmacotherapy and surgery.
引用
收藏
页码:582 / 588
页数:7
相关论文
共 50 条
  • [21] Weight Change and the Development of Nonalcoholic Fatty Liver Disease in Metabolically Healthy Overweight Individuals
    Cho, In Young
    Chang, Yoosoo
    Sung, Eunju
    Kang, Jae-Heon
    Shin, Hocheol
    Wild, Sarah H.
    Byrne, Christopher D.
    Ryu, Seungho
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2022, 20 (03) : E583 - E599
  • [22] The influence of puberty on body mass index change and pediatric nonalcoholic fatty liver disease
    Ng, Nicholas Beng Hui
    JOURNAL OF PEDIATRICS, 2023, 259
  • [23] Nonalcoholic Fatty Liver Disease: Diagnosis and Management
    Wilkins, Thad
    Tadkod, Altaf
    Hepburn, Iryna
    Schade, Robert R.
    AMERICAN FAMILY PHYSICIAN, 2013, 88 (01) : 35 - 42
  • [24] Diagnosis and Management of Nonalcoholic Fatty Liver Disease
    Paul, Sonali
    Davis, Andrew M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2018, 320 (23): : 2474 - 2475
  • [25] Weight loss as a treatment for nonalcoholic fatty liver disease
    Clark, JM
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (03) : S39 - S43
  • [26] Diagnosis and Management of Nonalcoholic Fatty Liver Disease
    Leung, Peggy B.
    Davis, Andrew M.
    Kumar, Sonal
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (17): : 1687 - 1688
  • [27] Nonalcoholic Fatty Liver Disease Pathophysiology and Management
    Carr, Rotonya M.
    Oranu, Amanke
    Khungar, Vandana
    GASTROENTEROLOGY CLINICS OF NORTH AMERICA, 2016, 45 (04) : 639 - +
  • [28] Pharmacological management of nonalcoholic fatty liver disease
    Barb, Diana
    Portillo-Sanchez, Paola
    Cusi, Kenneth
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08): : 1183 - 1195
  • [29] Pediatric nonalcoholic fatty liver disease: a multidisciplinary approach
    Anna Alisi
    Ariel E. Feldstein
    Alberto Villani
    Massimiliano Raponi
    Valerio Nobili
    Nature Reviews Gastroenterology & Hepatology, 2012, 9 : 152 - 161
  • [30] Effect of Weight Loss on Nonalcoholic Fatty Liver Disease
    Patel, Anish A.
    Torres, Dawn M.
    Harrison, Stephen A.
    JOURNAL OF CLINICAL GASTROENTEROLOGY, 2009, 43 (10) : 970 - 974